This time around SAMR approval will be much more valuable, if granted, compared to previously. Since the process acts to cull a lot of smaller producers and will consolidate the market around the larger players. A2M has punched above its weight when it comes to picking up market share when it is up for grabs, such as when Abbott's sales plummetted recently and Reckkitt left the market. So where there is risk (SAMR) its worth remembering there's also much reward.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.87 |
Change
0.040(0.51%) |
Mkt cap ! $5.643B | |||
| Open | High | Low | Value | Volume |
| $7.80 | $7.90 | $7.78 | $5.979M | 762.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 2862 | $7.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.88 | 5572 | 17 |
View Market Depth
| Last trade - 14.39pm 25/06/2025 (20 minute delay) ? |
| A2M (ASX) Chart |